Change in absolute lymphocyte count is not a biomarker of clinical response and does not correlate with change in serum neurofilament light for patients treated with delayed-release dimethyl fumarate

被引：0
|
作者：
Longbrake, E. E. [1 ]
Matthews, P. M. [2 ,3 ]
Mao-Draayer, Y. [4 ]
Foley, J. [5 ]
Zielinski, T. [6 ]
Barne, E. [7 ]
Chen, C. [7 ]
Mendoza, J. P. [7 ]
Mokliatchouk, O. [7 ]
Parks, B. [7 ]
Sharma, A. [7 ]
Xing, D. [7 ]
Plavina, T. [7 ]
机构：
[1] Yale Univ, New Haven, CT USA
[2] Imperial Coll, Hammersmith Hosp, Dept Med, London, England
[3] Imperial Coll, Hammersmith Hosp, Ctr Neurotechnol, London, England
[4] Univ Michigan, Sch Med, Dept Neurol, Autoimmun Ctr Excellence, Ann Arbor, MI USA
[5] Rocky Mt Multiple Sclerosis Clin, Salt Lake City, UT USA
[6] NOVOMED Zielinski, Katowice, Poland
[7] Biogen, Cambridge, MA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1037
引用
收藏
页码：552 / 553
页数：2
相关论文
共 19 条
  • [1] Absolute Lymphocyte Counts Are Not a Biomarker of Clinical Response in Patients Treated With Delayed-Release Dimethyl Fumarate
    Longbrake, Erin
    Mao-Draayer, Yang
    Matthews, Paul M.
    Foley, John
    Zielinski, Tomasz
    Chen, Chongshu
    Mokliatchouk, Oksana
    Parks, Becky
    Sharma, Ankur
    Xing, Diana
    Kapadia, Shivani
    Bame, Eris
    NEUROLOGY, 2020, 94 (15)
  • [2] Characterization of Absolute Lymphocyte Count Profiles in MS Patients Treated with Delayed-Release Dimethyl Fumarate: Considerations for Patient Management
    Fox, Robert
    Chan, Andrew
    Gold, Ralf
    Phillips, J. Theodore
    Selmaj, Krzysztof
    Zhang, Ray
    Chang, Ih
    Prada, Claudia
    Taylor, Catherine
    Marantz, Jing
    NEUROLOGY, 2016, 86
  • [3] Characterization of absolute lymphocyte count profiles in MS patients treated with delayed-release dimethyl fumarate: considerations for patient management
    Fox, R. J.
    Chan, A.
    Gold, R.
    Phillips, J. T.
    Selmaj, K.
    Zhang, R.
    Chang, I.
    Novas, M.
    Rana, J.
    Marantz, J. L.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 289 - 290
  • [4] Characterization of absolute lymphocyte count profiles in MS patients treated with delayed-release dimethyl fumarate: considerations for patient management
    Fox, Robert J.
    Chan, Andrew
    Gold, Ralf
    Phillips, Ted
    Selmaj, Krzysztof
    Zhang, Ray
    Chang, Ih
    Novas, Mark
    Ordonez, Claudia
    Rana, Jitesh
    Marantz, Jing
    NEUROLOGY, 2015, 85 (04) : E48 - E48
  • [5] Absolute Lymphocyte Count in Patients with Relapsing-Remitting Multiple Sclerosis Treated with Delayed-release Dimethyl Fumarate: Considerations for Patient Management
    Fox, Robert
    Chan, Andrew
    Gold, Ralf
    Phillips, J. Theodore
    Yang, Lili
    Liu, Shifang
    Prada, Claudia
    Ray, Soma
    Mehta, Devangi
    Taylor, Catherine
    Fay, Monica
    NEUROLOGY, 2017, 88
  • [6] Absolute lymphocyte count and lymphocyte subset profiles during long-term treatment with delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis
    Fox, Robert J.
    Chan, Andrew
    Gold, Ralf
    Phillips, J. Theodore
    Selmaj, Krzysztof
    Zhang, Ray
    Chang, Ih
    Prada, Claudia
    Ray, Soma
    Mehta, Devangi
    Taylor, Catherine
    Marantz, Jing
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 155 - 155
  • [7] Lymphocyte Decline and Reconstitution After Discontinuation in Patients With Severe, Prolonged Lymphopenia Treated With Delayed-Release Dimethyl Fumarate
    Fox, Robert J.
    Chan, Andrew
    Gold, Ralf
    Phillips, J. Theodore
    Yang, Lili
    Liu, Shifang
    Chalkias, Spyros
    Mehta, Devangi
    Taylor, Catherine
    NEUROLOGY, 2018, 90
  • [8] Absolute lymphocyte count and lymphocyte subset profiles during long-term treatment with delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis
    Fox, R. J.
    Chan, A.
    Gold, R.
    Phillips, J. T.
    Selmaj, K.
    Zhang, R.
    Chang, I.
    Prada, C.
    Ray, S.
    Mehta, D.
    Taylor, C.
    Marantz, J. L.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 349 - 349
  • [9] Lymphocyte decline and reconstitution after discontinuation in patients with severe, prolonged lymphopenia treated with delayed-release dimethyl fumarate
    Fox, R. J.
    Chan, A.
    Gold, R.
    Phillips, J. T.
    Yang, L.
    Liu, S.
    Chalkias, S.
    Mehta, D.
    Taylor, C.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 371 - 371
  • [10] Lymphocyte count reductions in relapsing-remitting multiple sclerosis (RRMS) patients treated with delayed-release dimethyl fumarate: integrated analysis of the placebo-controlled studies
    Fox, R. J.
    Chan, A.
    Gold, R.
    Phillips, J. T.
    Selmaj, K.
    Raghupathi, K.
    Yuan, H.
    O'Gorman, J.
    Novas, M.
    Viglietta, V.
    Kurukulasuriya, N. C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 343 - 343
12